Award5 Aug 2026, 09:39 am
Panacea Biotec Secures US$8.2M UNICEF Vaccine Order
AI Summary
Panacea Biotec Ltd has received a Letter of Award from UNICEF for the supply of bivalent Oral Polio Vaccine (bOPV) in 10 and 20 dose presentations. The order is valued at approximately US$8.205 million (around ₹78.24 Crore) and is to be executed in Calendar Year 2028. This award is in continuation of a previously announced Long-Term Agreement with UNICEF for bOPV supply from April 1, 2026, to March 31, 2030. The company confirmed no promoter or group company interest in UNICEF and that the contract is not a related party transaction.
Key Highlights
- Secured US$8.2 million contract from UNICEF for bOPV supply.
- Order execution scheduled for Calendar Year 2028.
- Part of a larger Long-Term Agreement with UNICEF.
- Contract is with an international entity.
- No related party transactions involved.
Price Impact
More from PANACEABIO